A University of Chicago study estimates that mandatory labeling of ultra-processed foods (UPFs) would impose at least $14.2 billion in annual costs on the industry, with 72% of packaged foods qualifying under the proposed rules. The financial burden would be unevenly distributed, with $9.5 billion allocated to reformulating products, $4.5 billion for substitute ingredients, and $200 million for federal administration and relabeling. Of this total, $8.1 billion would be passed directly to consumers—roughly $60 per household—though the study does not account for additional expenses such as lost agricultural revenue or higher import costs.
Public support for UPF regulations remains strong. An Annenberg Public Policy Center survey found that 80% of U.S. adults back mandatory UPF labels, 79% support banning highly processed foods from school lunches, and 75% favor stricter oversight of chemical additives. Even among Movement for a Healthy America supporters, who make up 26% of respondents, support for specific policies averages 73%. However, manufacturers face significant uncertainty. The FDA’s proposed UPF definition, submitted to the White House in August, remains unpublished. Without a final rule, companies cannot finalize ingredient sourcing, prioritize reformulation, or predict which products will exceed regulatory thresholds.
The delay forces brands to handle an uncertain environment. The University of Chicago study relied on a May 2026 Healthy Eating Research definition because the FDA’s version has yet to be released. Over 100 nutrition and medical experts urged the Office of Management and Budget to publish it in late October, but the definition remains stalled in interagency review. Meanwhile, consumer demand for transparency clashes with the lack of regulatory clarity, pushing up costs before any policy is even finalized.
Global food prices surge amid war-driven chaos
While regulatory debates unfold, global food prices are climbing faster than anticipated. The World Bank projects a 10% increase in 2026, followed by another 7% in 2027, driven by rising energy costs and supply chain disruptions linked to the Middle East conflict. Grain shipments through the Strait of Hormuz remain below pre-war levels, and worsening weather conditions have deepened fertilizer shortages. The bank warns that further escalation could trigger a food crisis similar to the sharp price spikes seen in the early 2010s.
Supply chain disruptions are already taking a toll. The second-largest egg-laying facility in the U.S., Rose Acre Farms in Illinois, culled 934,600 birds in October due to a bird flu outbreak. Since February 2022, over 210 million birds have been slaughtered nationwide, driving retail egg prices to $2.27 per dozen—still below the $6-plus peak of early 2025 but volatile enough to disrupt regional supply chains. A separate detection in a Washington dairy herd in mid-October adds another layer of cost uncertainty for dairy producers.
Related Post: California Health Laws Target Ultra-Processed Foods, Vaping
Retailers are capitalizing on the instability. Kroger’s private label operation, now a $40 billion business with 35 manufacturing sites, is expanding rapidly. Its premium tier, Private Selection, reached $2.9 billion in sales in 2025, with a target of $5 billion in three years. The value-focused Smart Way line is adding 1,000 new items, reducing shelf space for branded manufacturers already struggling with inflation. For these companies, the message is clear: without operational improvements or distinct market positioning, private label growth will continue to shrink their share.
GLP-1 drugs rewrite consumer diets and demand
The rise of GLP-1 drugs is further reshaping consumer behavior. An EY-Parthenon survey of 3,600 current and former users found that 66% are eating more fresh produce, 61% are increasing protein intake, and 63% are cutting back on sweets and salty snacks. Over half are dining out less frequently. Adoption of these drugs is projected to grow 20% annually through 2030, driven by falling prices and expanded insurance coverage. Yet Danone’s experience with high-protein yogurt demonstrates the risks of misjudging demand.
The company’s U.S. manufacturing capacity failed to meet surging demand for its Oikos and Activia lines, leading to supply disruptions and a leadership overhaul. Danone named Francois Lacombe as its US president to fix execution and retailer relationships heading into 2027. While Q3 North America like-for-like sales rose 2.4%, the growth was entirely price-driven, volume and mix actually declined by 0.6%. CFO Juergen Esser said 2027 needs to “look very different.”
Hidden costs deepen supply chain fragility
The financial strain from UPF labeling extends beyond direct compliance costs. The $14.2 billion estimate excludes an additional $1 billion in lost domestic agricultural revenue and up to $9.7 billion in higher food import expenses, according to the study. These hidden costs could further strain supply chains already disrupted by global price volatility. If tensions escalate, the bank warns of a food crisis comparable to the early 2010s, when prices spiked sharply.